Clinical Focus ›› 2026, Vol. 41 ›› Issue (9): 818-823.doi: 10.3969/j.issn.1004-583X.2026.09.006
Previous Articles Next Articles
Received:2025-12-03
Online:2026-09-20
Published:2026-09-17
Contact:
Lin Tao
E-mail:doctorlintao@163.com
CLC Number:
Lin Tao, Wu Weijun. Effects of early rehabilitation training on neurological recovery and serum neurotrophic factor levels in patients with cerebral infarction at medium-to-high altitudes[J]. Clinical Focus, 2026, 41(9): 818-823.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.lchc.cn/EN/10.3969/j.issn.1004-583X.2026.09.006
| 组别 | 例数 | 年龄(岁) | 男性[例(%)] | 高血压[例(%)] | 糖尿病[例(%)] | 入院NIHSS评分(分) |
|---|---|---|---|---|---|---|
| 康复组 | 160 | 63.2±8.5 | 98(61.3) | 115(71.9) | 52(32.5) | 9.8±2.3 |
| 对照组 | 160 | 64.1±9.0 | 102(63.8) | 110(68.8) | 48(30.0) | 10.1±2.5 |
| t/χ2值 | 1.024 | 0.217 | 0.383 | 0.235 | 1.158 | |
| P值 | 0.372 | 0.642 | 0.537 | 0.628 | 0.285 |
Tab.1 Comparison of baseline characteristics between the two groups
| 组别 | 例数 | 年龄(岁) | 男性[例(%)] | 高血压[例(%)] | 糖尿病[例(%)] | 入院NIHSS评分(分) |
|---|---|---|---|---|---|---|
| 康复组 | 160 | 63.2±8.5 | 98(61.3) | 115(71.9) | 52(32.5) | 9.8±2.3 |
| 对照组 | 160 | 64.1±9.0 | 102(63.8) | 110(68.8) | 48(30.0) | 10.1±2.5 |
| t/χ2值 | 1.024 | 0.217 | 0.383 | 0.235 | 1.158 | |
| P值 | 0.372 | 0.642 | 0.537 | 0.628 | 0.285 |
| 组别 | 例数 | 入院时 | 第7 d | 第30 d | 第90 d |
|---|---|---|---|---|---|
| 康复组 | 160 | 9.8±2.3 | 8.2±2.1 | 5.1±1.8* | 3.2±1.5* |
| 对照组 | 160 | 10.1±2.5 | 8.5±2.3 | 6.9±2.0 | 5.0±1.7 |
| 组间 | F=18.450 P<0.01 | ||||
| 时点间 | F=145.230 P<0.01 | ||||
| 组间·时点间 | F=8.672 P<0.01 | ||||
Tab.2 Comparison of NIHSS score between the two groups at different time points (point)
| 组别 | 例数 | 入院时 | 第7 d | 第30 d | 第90 d |
|---|---|---|---|---|---|
| 康复组 | 160 | 9.8±2.3 | 8.2±2.1 | 5.1±1.8* | 3.2±1.5* |
| 对照组 | 160 | 10.1±2.5 | 8.5±2.3 | 6.9±2.0 | 5.0±1.7 |
| 组间 | F=18.450 P<0.01 | ||||
| 时点间 | F=145.230 P<0.01 | ||||
| 组间·时点间 | F=8.672 P<0.01 | ||||
| 组别 | 例数 | BI | FMA | |||||
|---|---|---|---|---|---|---|---|---|
| 入院时 | 第30 d | 第90 d | 入院时 | 第30 d | 第90 d | |||
| 康复组 | 160 | 45.2±10.3 | 70.8±12.1* | 85.6±9.8* | 50.1±12.4 | 75.3±13.2* | 88.7±11.5* | |
| 对照组 | 160 | 44.8±9.7 | 60.3±11.5 | 72.4±10.2 | 49.6±11.8 | 65.2±12.6 | 76.8±12.3 | |
| 组间 | F=32.100 P<0.01 | F=28.960 P<0.01 | ||||||
| 时点间 | F=289.540 P<0.01 | F=245.780 P<0.01 | ||||||
| 组间·时点间 | F=11.240 P<0.01 | F=9.870 P<0.01 | ||||||
Tab.3 Comparison of BI and FMA scores between the two groups at different time points (point)
| 组别 | 例数 | BI | FMA | |||||
|---|---|---|---|---|---|---|---|---|
| 入院时 | 第30 d | 第90 d | 入院时 | 第30 d | 第90 d | |||
| 康复组 | 160 | 45.2±10.3 | 70.8±12.1* | 85.6±9.8* | 50.1±12.4 | 75.3±13.2* | 88.7±11.5* | |
| 对照组 | 160 | 44.8±9.7 | 60.3±11.5 | 72.4±10.2 | 49.6±11.8 | 65.2±12.6 | 76.8±12.3 | |
| 组间 | F=32.100 P<0.01 | F=28.960 P<0.01 | ||||||
| 时点间 | F=289.540 P<0.01 | F=245.780 P<0.01 | ||||||
| 组间·时点间 | F=11.240 P<0.01 | F=9.870 P<0.01 | ||||||
| 组别 | 例数 | BDNF | VEGF | |||||
|---|---|---|---|---|---|---|---|---|
| 入院时 | 第30 d | 第90 d | 入院时 | 第30 d | 第90 d | |||
| 康复组 | 160 | 856.3±125.6 | 1256.8±158.9* | 1423.5±167.2* | 185.6±45.3 | 256.3±52.1* | 285.6±48.7* | |
| 对照组 | 160 | 848.9±118.7 | 985.4±142.3 | 1056.8±153.4 | 182.9±43.8 | 205.4±46.2 | 218.9±45.3 | |
| 组间 | F=41.580 P<0.01 | F=35.210 P<0.01 | ||||||
| 时点间 | F=312.650 P<0.01 | F=198.450 P<0.01 | ||||||
| 组间·时点间 | F=15.320 P<0.01 | F=12.760 P<0.01 | ||||||
Tab.4 Comparison of serum BDNF and VEGF levels between the two groups at different time points (ng/L)
| 组别 | 例数 | BDNF | VEGF | |||||
|---|---|---|---|---|---|---|---|---|
| 入院时 | 第30 d | 第90 d | 入院时 | 第30 d | 第90 d | |||
| 康复组 | 160 | 856.3±125.6 | 1256.8±158.9* | 1423.5±167.2* | 185.6±45.3 | 256.3±52.1* | 285.6±48.7* | |
| 对照组 | 160 | 848.9±118.7 | 985.4±142.3 | 1056.8±153.4 | 182.9±43.8 | 205.4±46.2 | 218.9±45.3 | |
| 组间 | F=41.580 P<0.01 | F=35.210 P<0.01 | ||||||
| 时点间 | F=312.650 P<0.01 | F=198.450 P<0.01 | ||||||
| 组间·时点间 | F=15.320 P<0.01 | F=12.760 P<0.01 | ||||||
| 变量 | β值 | SE | Wald χ2值 | OR值 | 95%CI | P值 | |
|---|---|---|---|---|---|---|---|
| 下限 | 上限 | ||||||
| 康复训练 | -0.545 | 0.206 | 6.998 | 0.580 | 0.39 | 0.87 | 0.008 |
| 入院NIHSS评分 | 0.372 | 0.134 | 7.708 | 1.450 | 1.12 | 1.89 | 0.006 |
| 年龄 | 0.215 | 0.142 | 2.292 | 1.240 | 0.94 | 1.64 | 0.130 |
| 糖尿病 | 0.298 | 0.198 | 2.265 | 1.350 | 0.91 | 1.99 | 0.132 |
Tab.5 Logistic regression analysis of factors associated with favorable neurological recovery
| 变量 | β值 | SE | Wald χ2值 | OR值 | 95%CI | P值 | |
|---|---|---|---|---|---|---|---|
| 下限 | 上限 | ||||||
| 康复训练 | -0.545 | 0.206 | 6.998 | 0.580 | 0.39 | 0.87 | 0.008 |
| 入院NIHSS评分 | 0.372 | 0.134 | 7.708 | 1.450 | 1.12 | 1.89 | 0.006 |
| 年龄 | 0.215 | 0.142 | 2.292 | 1.240 | 0.94 | 1.64 | 0.130 |
| 糖尿病 | 0.298 | 0.198 | 2.265 | 1.350 | 0.91 | 1.99 | 0.132 |
| [1] | Cramer SC, Sur M, Dobkin BH, et al. Harnessing neuroplasticity for clinical applications[J]. Brain, 2022, 145(2): 625-636. doi:10.1093/brain/awab484. |
| [2] | Mang CS, Campbell KL, Ross CJD, et al. Promoting motor recovery after stroke: The role of brain-derived neurotrophic factor and exercise[J]. Neurorehabil Neural Repair, 2020, 34(10): 869-880. doi:10.1177/1545968320952674. |
| [3] | Wang Y, Cao L, Zhang Y, et al. Vascular endothelial growth factor as a key mediator of angiogenesis and neurogenesis after ischemic stroke[J]. Exp Neurol, 2021, 346: 113856. doi:10.1016/j.expneurol.2021.113856. |
| [4] | Burtscher J, Mallet RT, Burtscher M, et al. Adaptation to hypoxia: A key mechanism for brain resilience and a potential therapeutic target[J]. Neurosci Biobehav Rev, 2023, 144: 104968. doi:10.1016/j.neubiorev.2022.104968. |
| [5] | Zhang Q, Chen S, Wang S, et al. Exercise-induced BDNF signaling and its roles in neuroplasticity[J]. Front Mol Neurosci, 2023, 16: 1187295. doi:10.3389/fnmol.2023.1187295. |
| [6] | Li S, Zhang X, Wang Y, et al. VEGF: A potential target for post-stroke cognitive impairment[J]. Aging Dis, 2022, 13(3): 788-800. doi:10.14336/AD.2021.1123. |
| [7] | Luo Y, Li S, Wang Y, et al. Effects of high-altitude hypoxia on cognitive function and neuroplasticity[J]. Front Physiol, 2022, 13: 1025320. doi:10.3389/fphys.2022.1025320. |
| [8] | Stinear CM, Byblow WD, Ackerley SJ, et al. Advances and challenges in developing neuroimaging biomarkers of post-stroke recovery[J]. Stroke, 2023, 54(2): 645-654. doi:10.1161/STROKEAHA.122.038465. |
| [9] | Boyd LA, Hayward KS, Dancause N, et al. Biomarkers of stroke recovery: Consensus-based core recommendations from the stroke recovery and rehabilitation roundtable[J]. Neurorehabil Neural Repair, 2023, 37(7): 423-435. doi:10.1177/154596832311589. |
| [10] | Winstein CJ, Stein J, Arena R, et al. Guidelines for adult stroke rehabilitation and recovery: A guideline for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke, 2024, 55(3): e1-e89. doi:10.1161/STR.0000000000000449. |
| [11] | Langhorne P, Bernhardt J, Kwakkel G, et al. Stroke rehabilitation: Evidence, practice, and future directions[J]. Lancet Neurol, 2024, 23(1): 84-106. doi:10.1016/S1474-4422(23)00369-2. |
| [12] | Bernhardt J, Hayward KS, Kwakkel G, et al. Early mobilization after stroke: Early adoption but limited evidence[J]. Stroke, 2021, 52(4): 1484-1492. doi:10.1161/STROKEAHA.120.033434. |
| [13] | 张通, 李冰洁, 刘丽旭, 等. 中国脑卒中早期康复治疗指南(2022版)[J]. 中国脑血管病杂志, 2022, 19(11): 725-735. doi:10.3969/j.issn.1672-5921.2022.11.001. |
| [14] | GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet Neurol, 2021, 20(10): 795-820. doi:10.1016/S1474-4422(21)00252-0. |
| [15] | Campbell BCV, Khatri P, Hill MD, et al. Ischaemic stroke[J]. Nat Rev Dis Primers, 2023, 9(1): 1-23. doi:10.1038/s41572-023-00452-3. |
| [16] | Hordacre B, Moezzi B, Goldsworthy MR, et al. Understanding the mechanisms of recovery after stroke: How does rehabilitation promote neuroplasticity?[J]. Curr Neurol Neurosci Rep, 2021, 21(10): 54. doi:10.1007/s11910-021-01142-x. |
| [17] | Cassidy JM, Cramer SC, Bernhardt J, et al. Neural correlates of motor recovery after stroke: A longitudinal fMRI study[J]. Brain, 2020, 143(8): 2493-2507. doi:10.1093/brain/awaa212. |
| [18] | Hayward KS, Kramer SF, Dalton EJ, et al. Dosing of upper limb motor practice in stroke rehabilitation: A systematic review[J]. Int J Stroke, 2022, 17(5): 499-511. doi:10.1177/17474930211055857. |
| [19] | Veerbeek JM, van Wegen E, van Peppen R, et al. What is the evidence for physical therapy poststroke? A systematic review and meta-analysis[J]. PLoS One, 2020, 15(5): e0232859. doi:10.1371/journal.pone.0232859. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
